Analytical Data
-
基因名
FSTL1
- Application
-
别名
FSTL1；FRP;Follistatin-related Protein 1
-
种属
Human
-
表达系统
E. coli
-
标签
His tag N-Terminus
-
纯度
Greater than 90% as determined by SDS-PAGE.
-
蛋白编号
Q12841
-
表达区间
21-308aa
-
氨基酸序列
EEELRSKSKICANVFCGAGRECAVTEKGEPTCLCIEQCKPHKRPVCGSNG KTYLNHCELHRDACLTGSKIQVDYDGHCKEKKSVSPSASPVVCYQSNRDE LRRRIIQWLEAEIIPDGWFSKGSNYSEILDKYFKNFDNGDSRLDSSEFLK FVEQNETAINITTYPDQENNKLLRGLCVDALIELSDENADWKLSFQEFLK CLNPSFNPPEKKCALEDETYADGAETEVDCNRCVCACGNWVCTAMTCDGK NQKGAQTQTEEEMTRYVQELQKHQETAEKTKRVSTKEIHHHHHH
-
分子量
34 kDa
-
内毒素
< 1.0 EU per μg protein as determined by the LAL method.
-
性状
Freeze-dried powder
-
缓冲液
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
复溶方法
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- 个性化定制
-
稳定性测试
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
保存条件 & 期限
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
运输条件
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
FSTL1 (Fibroblast Growth Factor-Inducible 14) is a member of the Thrombospondin type-1 repeat-containing protein family and has emerged as a significant research focus due to its role in various physiological and pathological processes. Initially identified as a secreted protein induced by fibroblast growth factor (FGF), FSTL1 is implicated in modulating cell proliferation, differentiation, and survival in response to different stimuli, including tissue injury. Its expression is notably elevated in inflammatory conditions and certain cancers, suggesting a potential involvement in tumor progression and immune regulation. Research has highlighted FSTL1's dual role: it can exert protective effects in conditions such as cardiac injury and inflammatory diseases, while also promoting tumorigenesis in specific contexts. This complexity makes FSTL1 a crucial target for therapeutic strategies aiming to manipulate its signaling pathways for improved outcomes in cardiovascular diseases, cancer, and inflammatory disorders. Moreover, investigations into the biochemical properties and the structural characteristics of FSTL1 recombinant proteins are essential for understanding its functional mechanisms and interactions with other proteins. Overall, the study of FSTL1 offers valuable insights into its potential as a biomarker and therapeutic target, driving ongoing research in molecular biology and translational medicine.
